Single User License: $2500
Member Price: FREE
Use code SUMMER at checkout for 50% OFF
Already a member? Login to access this report free.
Report Highlights
The goal is to provide an analysis of the emerging tools for the early detection of Alzheimer’s disease (AD) and their growth potential and future opportunities in the market. Because currently available tools are invasive and very expensive, there is a significant unmet need for non-invasive, cost-effective and early-detection tools. The study’s main objective is to present a comprehensive analysis of the emerging tools, including those that are approved and those in development, and predict their impact on the market.
Report Includes
- An overview of the global market for emerging tools for the early detection of Alzheimer’s disease
- Estimation of the market size and analyses of global market trends, with data from 2020 to 2022, estimates for 2023 with projections of compound annual growth rates (CAGRs) through 2028
- Highlights of the current and future market potential and quantification of market based on type and region
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
- Detailed analysis of the regulatory framework and policies and product pipeline of the industry
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
Report Scope
The report provides an overview of AD, and the current diagnostic methods. The report explains the need for emerging tools for the early detection of the disease. Tools that have been approved are discussed, as well as tools in the development phase. The report does not include therapeutics approved or in the pipeline for AD.
The report covers the global market for emerging tools with a look at the regional markets of North America, Europe and Emerging Markets.
The report provides a detailed analysis of the current and future global market for emerging tools. Industry growth drivers, restraints and opportunities are also discussed. The report also provides a look at the competitive landscape, profiles of companies developing tools for the early detection of AD, and the impact of COVID-19 on the market.
Report Synopsis
Report Metrics | Details | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2022 | ||||||||||
Forecast period considered | 2023-2028 | ||||||||||
Base year market size | $814.7 million | ||||||||||
Market size forecast | $1.7 billion | ||||||||||
Growth rate | CAGR of 13.6% | ||||||||||
Units considered | $ Millions | ||||||||||
Segments covered | region | ||||||||||
Regions covered | North America, Europe, and Emerging Markets | ||||||||||
Key Market Drivers |
|
||||||||||
Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets
The global central nervous system (CNS) biomarkers market should reach $9.5 billion by 2027 from $5.7 billion in 2022 at a compound annual growth rate (CAGR) of 10.8% for the forecast period of 2022 to 2027.
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets
The global market for Alzheimer's disease treatment should grow from $4.8 billion in 2020 to $6.3 billion by 2025 with a compound annual growth rate (CAGR) of 5.5% during the period of 2020-2025.
Artificial Intelligence (AI) in Alzheimer's Applications
AI is impacting many sectors, including healthcare. Within this sector AI is providing breakthrough in diagnostics, therapeutics, patients recovery time and outcomes, and health management. AI is being applied in the diagnosis and treatment of various medical conditions, in particular to solve some of the critical issues related to hard-to-cure diseases, such as Alzheimer’s (AD). This report summarizes the most relevant applications of artificial intelligence in AD and the various categories of supervised learning algorithms used in Alzheimer’s and their applications.
Recent Reports
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Global Orthodontic and Orthopedic Market
The global market for orthodontic devices is expected to grow from $18.9 billion in 2023 and projected to reach $29.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023 to 2028.Report Includes
Global Medical Dynamometer Market
The global market for medical dynamometers is estimated to increase from $547.5 million in 2023 to reach $780.1 million by 2028, at a compound annual growth rate (CAGR) of 7.3% from 2023 through 2028.
Global Insulin Pen Market
This report examines the global insulin pen market. It includes a detailed analysis and prediction of commercially significant products such as reusable and disposable insulin pens. This report investigates global insulin pen market patterns and features between 2022–2028, offering valuable insights and forecasts.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More